342 related articles for article (PubMed ID: 21278557)
21. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.
Shitara Y; Sugiyama Y
Pharmacol Ther; 2006 Oct; 112(1):71-105. PubMed ID: 16714062
[TBL] [Abstract][Full Text] [Related]
22. Statins and plaque stability.
Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R
J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948
[TBL] [Abstract][Full Text] [Related]
23. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
Sadowitz B; Seymour K; Costanza MJ; Gahtan V
Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
[TBL] [Abstract][Full Text] [Related]
24. Statin myotoxicity: a review of genetic susceptibility factors.
Needham M; Mastaglia FL
Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
[TBL] [Abstract][Full Text] [Related]
25. Perspectives of the non-statin hypolipidemic agents.
Rozman D; Monostory K
Pharmacol Ther; 2010 Jul; 127(1):19-40. PubMed ID: 20420853
[TBL] [Abstract][Full Text] [Related]
26. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
27. Functional expression of human HMG-CoA reductase in Saccharomyces cerevisiae: a system to analyse normal and mutated versions of the enzyme in the context of statin treatment.
Wysocka-Kapcinska M; Lutyk-Nadolska J; Kiliszek M; Plochocka D; Maciag M; Leszczynska A; Rytka J; Burzynska B
J Appl Microbiol; 2009 Mar; 106(3):895-902. PubMed ID: 19187128
[TBL] [Abstract][Full Text] [Related]
28. A review of perioperative statin therapy for noncardiac surgery.
Skrlin S; Hou V
Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):283-90. PubMed ID: 21041202
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based use of statins for primary prevention of cardiovascular disease.
Minder CM; Blaha MJ; Horne A; Michos ED; Kaul S; Blumenthal RS
Am J Med; 2012 May; 125(5):440-6. PubMed ID: 22387091
[TBL] [Abstract][Full Text] [Related]
30. Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statins.
Algotsson A; Winblad B
Dement Geriatr Cogn Disord; 2004; 17(3):109-16. PubMed ID: 14739530
[TBL] [Abstract][Full Text] [Related]
31. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
[TBL] [Abstract][Full Text] [Related]
32. The use of statins in pediatrics: knowledge base, limitations, and future directions.
Belay B; Belamarich PF; Tom-Revzon C
Pediatrics; 2007 Feb; 119(2):370-80. PubMed ID: 17272627
[TBL] [Abstract][Full Text] [Related]
33. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
[TBL] [Abstract][Full Text] [Related]
34. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
Katz MS
Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
[TBL] [Abstract][Full Text] [Related]
35. [Statins and mitochondria].
Broniarek I; Jarmuszkiewicz W
Postepy Biochem; 2016; 62(2):77-84. PubMed ID: 28132458
[TBL] [Abstract][Full Text] [Related]
36. Influence of statins on MHC class I expression.
Singh P; Kohr D; Kaps M; Blaes F
Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
[TBL] [Abstract][Full Text] [Related]
37. Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: a comprehensive review.
Krishna RK; Issa O; Saha D; Macedo FY; Correal B; Santana O
Pulm Pharmacol Ther; 2015 Feb; 30():134-40. PubMed ID: 25173913
[TBL] [Abstract][Full Text] [Related]
38. 3-Hydroxy-3-methylglutaryl coenzyme A reductase in rainbow trout: effects of fasting and statin drugs on activities and mRNA transcripts.
Estey C; Chen X; Moon TW
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Apr; 147(3):386-98. PubMed ID: 18280795
[TBL] [Abstract][Full Text] [Related]
39. Statins and blood coagulation.
Undas A; Brummel-Ziedins KE; Mann KG
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):287-94. PubMed ID: 15569822
[TBL] [Abstract][Full Text] [Related]
40. Investigations of statins in heart failure: inflammatory biomarkers and hormones.
Khan BV; Rajagopalan S
Heart Fail Clin; 2008 Apr; 4(2):171-6. PubMed ID: 18433697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
